Syndax Pharmaceuticals Inc (SNDX)
20.30
-0.62
(-2.96%)
USD |
NASDAQ |
May 17, 16:00
20.30
0.00 (0.00%)
Pre-Market: 20:00
Syndax Pharmaceuticals Market Cap: 1.724B for May 17, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 17, 2024 | 1.724B |
| May 16, 2024 | 1.778B |
| May 15, 2024 | 1.865B |
| May 14, 2024 | 1.841B |
| May 13, 2024 | 1.782B |
| May 10, 2024 | 1.848B |
| May 09, 2024 | 1.867B |
| May 08, 2024 | 1.902B |
| May 07, 2024 | 1.970B |
| May 06, 2024 | 1.912B |
| May 03, 2024 | 1.874B |
| May 02, 2024 | 1.858B |
| May 01, 2024 | 1.867B |
| April 30, 2024 | 1.796B |
| April 29, 2024 | 1.808B |
| April 26, 2024 | 1.790B |
| April 25, 2024 | 1.748B |
| April 24, 2024 | 1.767B |
| April 23, 2024 | 1.782B |
| April 22, 2024 | 1.781B |
| April 19, 2024 | 1.768B |
| April 18, 2024 | 1.741B |
| April 17, 2024 | 1.762B |
| April 16, 2024 | 1.808B |
| April 15, 2024 | 1.837B |
| Date | Value |
|---|---|
| April 12, 2024 | 1.846B |
| April 11, 2024 | 1.897B |
| April 10, 2024 | 1.870B |
| April 09, 2024 | 1.955B |
| April 08, 2024 | 1.938B |
| April 05, 2024 | 1.945B |
| April 04, 2024 | 1.922B |
| April 03, 2024 | 2.022B |
| April 02, 2024 | 1.979B |
| April 01, 2024 | 2.021B |
| March 28, 2024 | 2.023B |
| March 27, 2024 | 1.960B |
| March 26, 2024 | 1.822B |
| March 25, 2024 | 1.907B |
| March 22, 2024 | 1.919B |
| March 21, 2024 | 1.944B |
| March 20, 2024 | 1.957B |
| March 19, 2024 | 1.888B |
| March 18, 2024 | 1.863B |
| March 15, 2024 | 1.999B |
| March 14, 2024 | 1.925B |
| March 13, 2024 | 2.019B |
| March 12, 2024 | 2.028B |
| March 11, 2024 | 2.003B |
| March 08, 2024 | 2.088B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
147.37M
Minimum
Oct 09 2019
2.088B
Maximum
Mar 08 2024
973.31M
Average
932.51M
Median
Mar 21 2022
Market Cap Benchmarks
| Geron Corp | 2.260B |
| Verastem Inc | 291.24M |
| Karyopharm Therapeutics Inc | 135.37M |
| Crinetics Pharmaceuticals Inc | 4.053B |
| Arvinas Inc | 2.236B |
Market Cap Related Metrics
| PS Ratio | 10.79 |
| Price to Book Value | 3.506 |
| Price | 20.30 |
| Earnings Yield | -15.87% |
| Operating PE Ratio | 57.51 |
| Normalized PE Ratio | 47.19 |